BioFocus DPI adds structural biology to its drug discovery services  26-8-2008
Mechelen, Belgium and Cambridge, UK; 26 August 2008 – Galapagos NV (Euronext: GLPG) and Sareum Holdings plc (AIM: SAR) announce today that Galapagos has acquired Sareum’s assets in drug discovery services, for a total cash consideration of €695,000... » read more

UCB transfers UK-based medicinal chemistry program to BioFocus DPI  12-8-2008
Galapagos NV announced today that its service division BioFocus DPI and UCB have signed a contract for the provision of chemistry services in the UK by BioFocus DPI, for one of UCB's medicinal chemistry programs.  The total contract value for... » read more

BioFocus DPI transfers predictive drug discovery databases to EMBL’s European Bioinformatics Institute  23-7-2008
BioFocus DPI announces the transfer of its databases for predictive drug discovery to the EMBL’s European Bioinformatics Institute (EMBL-EBI).  The data will become publicly available on-line to drug discovery researchers worldwide through the... » read more